Review
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Diabetes. Apr 15, 2014; 5(2): 146-159
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.146
Knockout mouse models of insulin signaling: Relevance past and future
Anne E Bunner, P Charukeshi Chandrasekera, Neal D Barnard
Anne E Bunner, P Charukeshi Chandrasekera, Neal D Barnard, Physicians Committee for Responsible Medicine, Washington, DC 20016, United States
Author contributions: Bunner AE wrote the manuscript; Chandrasekera PC contributed to scientific content; Bunner AE, Chandrasekera PC and Barnard ND edited the manuscript.
Correspondence to: Anne E Bunner, Associate Director for Clinical Research, Physicians Committee for Responsible Medicine, 5100 Wisconsin Avenue, NW Ste. 400, Washington, DC 20016, United States. abunner@pcrm.org
Telephone: +1-202-5277379 Fax: +1-202-5277479
Received: October 16, 2013
Revised: February 11, 2014
Accepted: February 20, 2014
Published online: April 15, 2014
Core Tip

Core tip: Insulin resistance is central to the pathophysiology of type 2 diabetes. The molecular origins of insulin resistance have been investigated using genetically modified mice. Much has been learned from this work, but new treatments for insulin resistance have not been forthcoming. Knockout mouse models of diabetes are limited by several factors including species differences in glucose metabolism. These are due partly to species differences in physiology, and partly to the failure of genetic modifications to produce an accurate model. Advancement may require a redirection of research efforts toward methods that are more directly relevant to human physiology.